Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial.

This judgment is, however, challenging in critically ill patients in whom clinical signs of infection are non-specific and where the consequences of missing a treatable infection may be significant.

also in 13,097 other papers